(Q42595157)

3 November 2017

A 12-month, randomized, double-masked study comparing latanoprost with timolol in pigmentary glaucoma (English)

1 reference

3 November 2017

1 reference

Mastropasqua L

1

1 reference

3 November 2017

Carpineto P

series ordinal

2

1 reference

3 November 2017

Ciancaglini M

series ordinal

3

1 reference

3 November 2017

Gallenga PE

series ordinal

4

1 reference

3 November 2017

1 March 1999

1 reference

3 November 2017

1 reference

3 November 2017

106

1 reference

3 November 2017

3

1 reference

3 November 2017

550-555

1 reference

Effects of PhXA41, a new prostaglandin F2 alpha analog, on aqueous humor dynamics in human eyes

3 November 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2899%2990115-X

7 January 2021

The effects on aqueous dynamics of PhXA41, a new prostaglandin F2 alpha analogue, after topical application in normal and ocular hypertensive human eyes

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2899%2990115-X

7 January 2021

A six-month, randomized, double-masked study comparing latanoprost with timolol in open-angle glaucoma and ocular hypertension. The Latanoprost Study Group.

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2899%2990115-X

7 January 2021

Comparison of latanoprost and timolol in patients with ocular hypertension and glaucoma: a six-month masked, multicenter trial in the United States. The United States Latanoprost Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2899%2990115-X

7 January 2021

Effects on IOP restoration and blood-aqueous barrier after long-term treatment with latanoprost in open angle glaucoma and ocular hypertension

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2899%2990115-X

7 January 2021

Pigmentary dispersion and glaucoma. A new theory

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2899%2990115-X

7 January 2021

Effects on intraocular pressure and side effects of 0.005% latanoprost applied once daily, evening or morning. A comparison with timolol. Scandinavian Latanoprost Study Group.

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2899%2990115-X

7 January 2021

A 6-month, randomized, double-masked comparison of latanoprost with timolol in patients with open angle glaucoma or ocular hypertension.

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2899%2990115-X

7 January 2021

A comparison of latanoprost and timolol in primary open-angle glaucoma and ocular hypertension. A 12-week study

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2899%2990115-X

7 January 2021

Hypertrichosis and increased pigmentation of eyelashes and adjacent hair in the region of the ipsilateral eyelids of patients treated with unilateral topical latanoprost

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2899%2990115-X

7 January 2021

10.1016/S0161-6420(99)90115-X

Identifiers

DOI

1 reference

3 November 2017

1 reference